ElektaNeuromag

Elekta Neuromag is a leading provider of advanced neuroimaging and neurophysiological technologies, specializing in the development and manufacturing of high-resolution magnetoencephalography (MEG) systems. Founded in 1992, the company is a subsidiary of Elekta AB, a global leader in medical technology, and is headquartered in Helsinki, Finland, with additional offices worldwide.

Neuromag’s primary product, the MEG system, is designed to measure and map brain activity with millisecond precision by detecting magnetic fields generated by neuronal currents. The technology complements other neuroimaging modalities like functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), offering unique insights into brain function, connectivity, and dynamics. The company’s systems are widely used in research institutions, hospitals, and clinical settings for applications such as epilepsy monitoring, cognitive neuroscience, and the study of brain disorders.

Elekta Neuromag’s MEG systems incorporate superconducting quantum interference devices (SQUIDs) to achieve high sensitivity and spatial resolution. The company also develops software tools for data acquisition, analysis, and visualization, including MaxFilter for artifact correction and Brainstorm for neuroimaging research. These solutions enable scientists and clinicians to explore brain function in unprecedented detail.

Beyond MEG, Elekta Neuromag contributes to broader neurotechnology innovation by collaborating with academic and industrial partners. The company emphasizes user-friendly interfaces, robust hardware, and continuous advancements to support cutting-edge neuroscience research and clinical diagnostics. Its technologies play a key role in advancing our understanding of brain function and developing targeted treatments for neurological and psychiatric conditions.